Lungenkarzinom
Reference8 articles.
1. Früh M, De Ruysscher D, Popat S et al.; ESMO Guidelines Working Group. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Oct;24 Suppl 6 (2013) vi99–105. doi:10.1093/annonc/mdt178. Epub 2013 Jun 27. PMID: 23813929 2. ESMO Guidelines Committee: Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Oct 1;29(Suppl 4) (2018) iv192-iv237. doi:10.1093/annonc/mdy275. Erratum in: Ann Oncol May;30(5) (2019) 863-870. PMID: 30285222 3. Planchard D, Popat S, Kerr K et al.;1; ESMO Guidelines Committee: Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Oct 1;29(Suppl 4) (2018) iv192-iv237. doi:10.1093/annonc/mdy275. Erratum in: Ann Oncol May;30 4. (5) (2019) 863-870. PMID: 30285222 5. Postmus PE, Kerr KM, Oudkerk M et al. ESMO Guidelines Committee. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Jul 1 (2017 ) 28(suppl_4) iv1–iv21. doi:10.1093/annonc/mdx222. PMID: 28881918
|
|